Difference between revisions of "HaCaT Eicosanoid Analysis Results"
Line 1: | Line 1: | ||
[[Welcome to the In-Silico Model of Cutaneous Lipids Wiki | Return to overview]] | [[Welcome to the In-Silico Model of Cutaneous Lipids Wiki | Return to overview]] | ||
+ | The aim of this study was to investigate the levels of AA derived lipid mediators in the supernatant following stimulation of cells with A23187 (with and without COX inhibition), ATP and UVR. LC-MS/MS was used for the eicosanoid analysis and the values were normalized using cell numbers (pg/10^6 cells). | ||
== Calcium Ionophore == | == Calcium Ionophore == |
Latest revision as of 07:01, 3 June 2019
The aim of this study was to investigate the levels of AA derived lipid mediators in the supernatant following stimulation of cells with A23187 (with and without COX inhibition), ATP and UVR. LC-MS/MS was used for the eicosanoid analysis and the values were normalized using cell numbers (pg/10^6 cells).
Calcium Ionophore
Time (h) | Mediator | |||||
---|---|---|---|---|---|---|
PGE2 | 15-keto-PGE2 | 13,14-dihydro-15-keto-PGE2 | PGF2α | 12-HETE | 15-HETE | |
0 | 9.45 ± 7.56 | 0.50 ± 0.00 | 2.00 ± 0.00 | 7.00 ± 0.00 | 6.44 ± 4.40 | 3.72 ± 1.08 |
0.5 | 601.26 ± 162.02 | 65.52 ± 57.95 | 211.38 ± 61.05 | 106.06 ± 39.89 | 19.49 ± 10.36 | 163.26 ± 143.10 |
1 | 14371.34 ± 858.76 | 2136.87 ± 588.92 | 2461.84 ± 452.79 | 2787.86 ± 489.04 | 363.25 ± 96.91 | 4050.14 ± 2998.16 |
3 | 79576.88 ± 15355.19 | 12230.83 ± 2179.66 | 11025.93 ± 2287.76 | 19276.46 ± 3732.43 | 4872.78 ± 849.95 | 41799.69 ± 31552.30 |
6 | 111115.14 ± 32976.86 | 18619.32 ± 5691.99 | 15799.31 ± 5867.25 | 34965.99 ± 11250.10 | 7156.92 ± 1550.86 | 55738.98 ± 40130.05 |
ATP
Time (h) | Mediator | |||||
---|---|---|---|---|---|---|
PGE2 | 15-keto-PGE2 | 13,14-dihydro-15-keto-PGE2 | PGF2α | 12-HETE | 15-HETE | |
0 | 1.50 ± 0.00 | 0.37 ± 0.21 | 2.50 ± 0.00 | 7.50 ± 0.00 | 1.00 ± 0.00 | 2.00 ± 0.00 |
0.5 | 617.77 ± 60.96 | 1.10 ± 0.58 | 51.51 ± 6.47 | 96.88 ± 13.81 | 49.56 ± 37.94 | 15.82 ± 9.10 |
1 | 849.12 ± 56.72 | 3.60 ± 0.79 | 86.88 ± 32.86 | 148.10 ± 20.14 | 32.28 ± 31.72 | 10.95 ± 9.46 |
3 | 833.49 ± 170.07 | 2.05 ± 0.65 | 106.43 ± 12.88 | 170.02 ± 34.73 | 34.05 ± 39.23 | 5.70 ± 7.02 |
6 | 1015.73 ± 88.65 | 2.43 ± 1.70 | 141.16 ± 9.62 | 210.30 ± 43.78 | 9.76 ± 10.52 | 2.22 ± 0.54 |
UVR
Time (h) | Mediator | |||||
---|---|---|---|---|---|---|
PGE2 | 15-keto-PGE2 | 13,14-dihydro-15-keto-PGE2 | PGF2α | 12-HETE | 15-HETE | |
0 | 203.29 ± 315.50 | 0.50 ± 0.00 | 2.00 ± 0.00 | 0.00 ± 0.00 | 3.50 ± 0.00 | 2.30 ± 0.00 |
0.5 | 1.50 ± 0.00 | 0.75 ± 0.39 | 2.00 ± 0.00 | 88.72 ± 33.06 | 135.07 ± 142.32 | 40.09 ± 35.24 |
1 | 69.26 ± 60.99 | 1.05 ± 0.99 | 2.29 ± 1.56 | 90.56 ± 11.96 | 131.60 ± 100.39 | 46.54 ± 35.33 |
3 | 1.50 ± 0.00 | 9.61 ± 7.15 | 3.53 ± 2.41 | 222.44 ± 6.73 | 103.71 ± 78.12 | 58.45 ± 43.57 |
6 | 5667.91 ± 4967.29 | 152.58 ± 51.19 | 6.21 ± 4.30 | 1657.38 ± 297.77 | 766.69 ± 206.41 | 648.45 ± 219.84 |
Calcium ionophore + Indomethacin
Time (h) | Mediator | |||||
---|---|---|---|---|---|---|
PGE2 | 15-keto-PGE2 | 13,14-dihydro-15-keto-PGE2 | PGF2α | 12-HETE | 15-HETE | |
0 | 26.81 ± 10.56 | 0.50 ± 0.00 | 2.00 ± 0.00 | 7.00 ± 0.00 | 0.29 ± 0.00 | 1.92 ± 0.94 |
0.5 | 34.23 ± 22.16 | 0.50 ± 0.00 | 1.88 ± 0.57 | 7.00 ± 0.00 | 7.20 ± 10.94 | 29.71 ± 60.25 |
1 | 25.85 ± 9.25 | 0.50 ± 0.00 | 32.91 ± 28.56 | 7.00 ± 0.00 | 141.09 ± 24.66 | 54.23 ± 51.50 |
3 | 4731.85 ± 7300.78 | 2266.13 ± 371.89 | 1817.62 ± 907.18 | 3268.46 ± 658.45 | 17918.03 ± 8595.61 | 55405.98 ± 17910.03 |
6 | 4843.70 ± 7474.03 | 1620.01 ± 317.98 | 900.50 ± 199.18 | 4754.66 ± 596.47 | 61471.62 ± 16768.21 | 105543.44 ± 41314.43 |